Primaquine Phosphate NDC 50742-191

NDC codes

FDA NDC Directory

Product NDC (as listed)50742-191Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50742-0191Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50742-191-01	50742019101	100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50742-191-01)Marketed from Jan 23, 2018
50742-191-05	50742019105	500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50742-191-05)Marketed from Jan 23, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Primaquine Phosphate
Generic name (nonproprietary): primaquine phosphate
Active ingredients: Primaquine phosphate — 15 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Ingenus Pharmaceuticals, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206043
Marketing start: Jan 23, 2018
Listing expires: Dec 31, 2027
Identifiers: Product ID 50742-191_0d416a06-fb95-4a01-97c8-02e28ee99c2aSPL ID 0d416a06-fb95-4a01-97c8-02e28ee99c2a
Pharmacologic class: Antimalarial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450742019101 followed by a unit qualifier and the quantity

Package 50742-0191-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 206043

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206043
Product	Strength	Form · route	Labeler	Product NDC
Primaquine Phosphate	Primaquine phosphate 15 mg/1	Tablet, Film coatedOral	AvKARE	42291-510